Those results are a significant improvement from the $201.1 million operating surplus on $5.1 billion in revenue for the same period of 2013.
Ascension’s net patient revenue grew to $5.1 billion in the three months ended Dec. 31, 2014, up from $4.8 billion in the comparable period of the prior year.
However, with a $107.8 million loss on its investments, the system’s net surplus for the three months ended Dec. 31, 2014 was $114.8 million, down from $571.4 million for the same period of the preceding year.
More articles on healthcare finance:
7 hospitals receive credit downgrades in past month
Trends in the RCM environment: Q&A with Greenberg Advisors’ CEO
Partners HealthCare’s operating income spikes to $74M
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
